---
title: "CANADA RESEARCH ROUNDUP-CGI, Kinaxis and Lumine Group"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273664890.md"
datetime: "2026-01-26T07:36:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273664890.md)
  - [en](https://longbridge.com/en/news/273664890.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273664890.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273664890.md) | [English](https://longbridge.com/en/news/273664890.md)


# CANADA RESEARCH ROUNDUP-CGI, Kinaxis and Lumine Group

Jan 26 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including CGI, Kinaxis and Lumine Group, on Monday.

### HIGHLIGHTS

-   CGI Inc (GIBa.TO) : RBC cuts target price to C$150 from C$165
-   Kinaxis Inc (KXS.TO) : RBC cuts target price to C$200 from C$235
-   Lumine Group Inc (LMN.V) : RBC cuts target price to C$42 from C$50

The following is a summary of research actions on Canadian companies reported by Reuters on Monday. Stock entries are in alphabetical order.

-   CGI Inc (GIBa.TO) : RBC cuts target price to C$150 from C$165
-   Constellation Software Inc (CSU.TO) : RBC cuts target price to C$4,800 from C$5,600
-   Kinaxis Inc (KXS.TO) : RBC cuts target price to C$200 from C$235
-   Lumine Group Inc (LMN.V) : RBC cuts target price to C$42 from C$50
-   Topicus.Com Inc (TOI.V) : RBC cuts target price to C$160 from C$190

### 相關股票

- [CGI (GIB.US)](https://longbridge.com/zh-HK/quote/GIB.US.md)

## 相關資訊與研究

- [Suffolk County, New York, successfully upgrades financial management system with CGI Advantage® | GIB Stock News](https://longbridge.com/zh-HK/news/281362314.md)
- [CGI launches new AI capabilities in CGI Credit Studio to transform collections operations | GIB Stock News](https://longbridge.com/zh-HK/news/281169382.md)
- [VSBLTY to Raise Up to C$7 Million in Private Placement, Grants New RSUs](https://longbridge.com/zh-HK/news/281104034.md)
- [Boardwalktech Raises C$384,800 in First Tranche of Private Placement](https://longbridge.com/zh-HK/news/281385232.md)
- [Boston Scientific's 2026 Guidance 'Reasonable', RBC Says](https://longbridge.com/zh-HK/news/281545889.md)